Search

Your search keyword '"Embryonic antigen"' showing total 31 results
Start Over "Embryonic antigen" Topic antigens Publication Type News
31 results on '"Embryonic antigen"'

1. Study Results from Zhengzhou University of Light Industry Update Understanding of Cancer (Bifunctional bioplatform based on NiCo Prussian blue analogue: Label-free impedimetric aptasensor for the early detection of carcino-embryonic antigen and ...)

Subjects
Antigens, Cancer, Cancer research, Cancer cells, Fluorescence, Editors, Novels
Abstract

2019 NOV 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Cancer have been presented. According to news reporting from Henan, [...]

Published
2019

2. Data on Carcinomas Reported by Researchers at Luminescent MD LLC (Chemiluminescent dual-enzyme immunoassays capable of simultaneously quantifying carbohydrate antigen 19-9 and carcinoma embryonic antigen in a sample)

Subjects
Immunoassay enzymes, Antigens, Carcinoma, Peroxidase, Cancer, Phosphatases, Editors, Enzymes
Abstract

2019 JUL 5 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Oncology - Carcinomas are presented in a new report. According [...]

Published
2019

3. Reports on Colon Cancer from Department of Clinical Laboratory Provide New Insights (The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer)

Subjects
Diagnosis, Antigens, Biomedical laboratories, Colorectal cancer -- Diagnosis
Abstract

By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in Oncology. According to news reporting from Tianjin, People's Republic of China, by NewsRx journalists, research [...]

Published
2015

4. Dk 021:2015 - 33690000-3: Various Medicinal Products (reagents And Contrast Agents) (nc Code: 024:2023 'classifier Of Medical Products': 42703 Enzyme For Sample Preparation, Ivd (in Vitro Diagnostics); 58237 Buffer Solvent For Ivd Samples ( In Vitro Diagn

Subjects
Automated Systems Inc., Diagnostic reagents, Diagnostic reagents and test kits, Biological products, Thyroxine, Antigens, Medical testing products, Enzymes, Business, international
Abstract

Tenders Are Invited For: Dk 021:2015 - 33690000-3: Various Medicinal Products (Reagents And Contrast Agents) (Nc Code: 024:2023 'Classifier Of Medical Products': 42703 Enzyme For Sample Preparation, Ivd (In Vitro [...]

Published
2024

6. Patent Application Titled 'Humanized Anti-Sialyl-Tn Glycan Antibodies And Uses Thereof' Published Online (USPTO 20240197882)

Subjects
Intellectual property, Antigens, Amino acids -- Intellectual property, Antibodies, Biological products -- Intellectual property, Viral antibodies
Abstract

2024 JUL 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2024

7. Oncternal Therapeutics Announces Presentation of ROR1 CAR-T Preclinical Data at 2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Subjects
Ibrutinib -- Conferences, meetings and seminars, Conferences and conventions -- Conferences, meetings and seminars, Vincristine -- Conferences, meetings and seminars, Leukemia -- Conferences, meetings and seminars, T cells -- Conferences, meetings and seminars, Antigens, Cancer, Immunotherapy, Tumors, Professional associations, Business, Business, international
Abstract

- Anti-ROR1 CAR-T cell therapy demonstrated expansion, persistence and anti-tumor activity in animal model of human leukemia SAN DIEGO -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused [...]

Published
2020

8. Sensei Biotherapeutics Announces Clinical Trial Collaboration Agreement with AstraZeneca for Two Phase 2 Studies of SNS-301

Subjects
AstraZeneca PLC -- Product development, Pharmaceutical industry -- Product development -- Health aspects, Aspartate -- Product development -- Health aspects, Clinical trials -- Health aspects, Immunotherapy -- Health aspects, Cancer vaccines -- Product development -- Health aspects, Monoclonal antibodies -- Health aspects, Durvalumab -- Product development -- Health aspects, Death, Vaccines, Cancer, Antigens, Tumors, Antibodies, Business, Business, international, Imfinzi (Medication) -- Health aspects
Abstract

Trials to Evaluate the Safety, Tolerability and Preliminary Activity of Sensei's SNS-301, in Combination with IMFINZI[R] (durvalumab), in Multiple Solid Tumor Types GAITHERSBURG, Md. -- Sensei Biotherapeutics, Inc., a clinical-stage [...]

Published
2019

9. Monoclonal Antibody Diagnostic Reagents Market -Size, Share, and Analysis, 2018-2026

Subjects
Prostate cancer, Monoclonal antibodies, Medical research, Colorectal cancer, Diagnostic reagents, Biological products, Reagents, Cancer, Biological markers, Antigens, Microbiological research, Chlamydia, Herpesvirus infections, Antibodies, Proteins, Herpes simplex, Microbiology, HIV, Hepatitis, Infection, Influenza, General interest, World Health Organization
Abstract

New Delhi, April 22 -- Monoclonal antibodies (MAbs) are important diagnostic reagents used in biomedical research, microbiological research, in diagnosis of chlamydia, hepatitis, herpes simplex, HIV, and influenza infections, and [...]

Published
2019

10. FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolumab (Opdivo(R))

Subjects
Bristol-Myers Squibb Co. -- Product development, Pharmaceutical industry -- Product development, Nivolumab, Small cell lung cancer, Clinical trials, Monoclonal antibodies, Non-small cell lung cancer, Carcinoembryonic antigen, Antigens, Lung cancer, Antibodies, Banking, finance and accounting industries, Business, Opdivo (Medication)
Abstract

TEL AVIV, Israel, Apr 12, 2019 (GLOBE NEWSWIRE via COMTEX) -- FameWave Ltd. a privately held biopharmaceutical company developing CM-24, which is being acquired by Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), [...]

Published
2019

11. Sensei Biotherapeutics Presents First Preclinical Data on SNS-723 CAR-T and Long-Term Results on SNS-301 Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting

Subjects
Cancer, T cells, Cancer research, Immunotherapy, Antigens, Aspartate, Immune response, General interest, News, opinion and commentary, American Association for Cancer Research
Abstract

GAITHERSBURG: Sensei Biotherapeutics, Inc. has issued the following press release: Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced new data from two programs targeting a [...]

Published
2019

14. Sensei Biotherapeutics Reports Results from Phase 1 Clinical Trial of SNS-301, a First-in-Class Cancer Immunotherapy Targeting ASPH, a Novel Tumor-Specific Antigen

Subjects
Clinical trials, Antigens, Cancer -- Drug therapy, Immunotherapy, General interest, News, opinion and commentary
Abstract

GAITHERSBURG: Sensei Biotherapeutics has issued the following press release: -Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, announced today the results of the Phase 1 clinical trial [...]

Published
2018

15. Sensei Biotherapeutics Reports Results from Phase 1 Clinical Trial of SNS-301, a First-in-Class Cancer Immunotherapy Targeting ASPH, a Novel Tumor-Specific Antigen

Subjects
Clinical trials, Antigens, Cancer -- Drug therapy, Aspartate -- Product development, Immunotherapy, Business, Business, international
Abstract

SNS-301 demonstrated a favorable safety profile, improvements in disease parameters, and robust antigen-specific immune responses Clinical results presented in Poster Discussion session at ESMO 2018 Company to initiate Phase 2 [...]

Published
2018

16. Sensei Biotherapeutics to Present Clinical Data at Upcoming Oncology Medical Conferences

Subjects
Antigens, Conferences and conventions, Aspartate, Immunotherapy, Business, Business, international, European Society for Medical Oncology
Abstract

Data to highlight SNS-301, a first-in-class cancer immunotherapy targeting ASPH, a novel tumor-specific antigen GAITHERSBURG, Md. -- Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing precision immuno-oncology therapies, [...]

Published
2018

17. Recent Findings from Gifu University Has Provided New Data on Molecular Research (Development of Fluorescently Labeled SSEA-3, SSEA-4, and Globo-H Glycosphingolipids for Elucidating Molecular Interactions in the Cell Membrane)

Subjects
Research, Lipids -- Research, Fluorescence -- Research, Stem cells -- Research, Cellular signal transduction -- Research, Cell membranes, Antigens, Cancer cells, Editors
Abstract

2019 DEC 27 (NewsRx) -- By a News Reporter-Staff News Editor at Science Letter -- Data detailed on Molecular Research have been presented. According to news reporting out of Gifu, [...]

Published
2019

18. Researchers Submit Patent Application, 'Chimeric Antigen Receptors That Bind To Ssea4 And Uses Thereof', for Approval (USPTO 20190290744)

Subjects
Intellectual property, Antigens, Cancer vaccines -- Intellectual property, Amino acids -- Intellectual property, Immunotherapy, Vaccines, Chemotherapy, Cancer treatment, Anopheles, Cancer, Proteomics, Tumors, Editors
Abstract

2019 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at Proteomics Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor Chen, Lan [...]

Published
2019

19. Researchers from Wuhan University Provide Details of New Studies and Findings in the Area of Photocatalytics (Z-scheme I-BiOCl/CdS with abundant oxygen vacancies as highly effective cathodic material for photocathodic immunoassay)

Subjects
Research, Reports, Antigens, Labels, Nanotechnology, Editors, Novels
Abstract

2019 JUL 12 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Nanotechnology - Photocatalytics. According to news reporting originating [...]

Published
2019

20. Studies from Institute for Cancer Research Provide New Data on Colon Cancer [Cea Expression Heterogeneity and Plasticity Confer Resistance To the Cea-targeting Bispecific Immunotherapy Antibody Cibisatamab (Cea-tcb) In Patient-derived Colorectal ...]

Subjects
Reports, T cells -- Reports, Colon cancer -- Reports, Cancer research -- Reports, Immunotherapy -- Reports, Cancer patients -- Reports, Antibodies -- Reports, Colorectal cancer, Antigens, Tumors, Cancer cells, Editors
Abstract

2019 MAY 15 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New research on Oncology - Colon Cancer is the subject of a report. According to [...]

Published
2019

23. GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program

Subjects
Cancer treatment, Antigens, Vaccines, Cancer -- Drug therapy, Vaccination, Genomics, Biological products industry, General interest, News, opinion and commentary
Abstract

Atlanta, GA: GeoVax has issued the following news release: GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with Vaxeal Holding SA [...]

Published
2018

24. GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program

Subjects
Antigens, Vaccines, Cancer -- Drug therapy, Vaccination, Genomics, Biological products industry, Banking, finance and accounting industries, Business
Abstract

ATLANTA, GA, Jan 03, 2018 (GLOBE NEWSWIRE via COMTEX) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with Vaxeal Holding [...]

Published
2018

25. Sensei Biotherapeutics Reports Results from Phase 1 Clinical Trial of SNS-301, a First-in-Class Cancer Immunotherapy Targeting ASPH, a Novel Tumor-Specific Antigen

Subjects
European Society for Medical Oncology, Drug therapy, Product development, Clinical trials, Antigens, Cancer -- Drug therapy, Immunotherapy
Abstract

2018 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Oncology Business Week -- Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, announced the results [...]

Published
2018

26. Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology

Subjects
Antigens, Dendritic cells, T cells, Business, News, opinion and commentary
Abstract

NEW YORK, Dec. 16, 2016 /PRNewswire/ --Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology This product consists of four reports in pdf format describing the competitive field of new molecular [...]

Published
2016

27. Researchers Submit Patent Application, 'Anti-Ssea4 Chimeric Antigen Receptors and Their Use for Treating Cancer', for Approval (USPTO 20180028631)

Subjects
Intellectual property, Patent/copyright issue, Cancer treatment, Antigens, Cancer vaccines -- Intellectual property, Cancer, Patents, Immunotherapy
Abstract

2018 FEB 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Vaccine Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor Chen, [...]

Published
2018

29. GEOVAX AND VAXEAL COLLABORATE ON CANCER PROGRAM

Subjects
Antigens, Cancer, Vaccination, Genomics, Biotechnology industry, Business
Abstract

GeoVax Labs, Inc. has collaborated with Vaxeal Holding SA on the expansion of GeoVax's cancer immunotherapy program. GeoVax's immuno-oncology program is based on its Modified Vaccinia Ankara (MVA) Virus-Like Particle [...]

Published
2018

31. New Findings from National Taiwan University Describe Advances in Cancer Vaccines (Immunogenicity Study of Globo H Analogues with Modification at the Reducing or Nonreducing End of the Tumor Antigen)

Subjects
National Taiwan University, Antigens, Cancer vaccines, Cancer research, Tumors
Abstract

By a News Reporter-Staff News Editor at Vaccine Weekly -- New research on Immunization is the subject of a report. According to news reporting originating in Taipei, Taiwan, by NewsRx [...]

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results